Definium Therapeutics (DFTX) Stock Soars to New Heights on Trump’s Psychedelic Research Order

Key Takeaways Shares of DFTX climbed more than 13% during premarket hours following President Trump’s Executive Order promoting psychedelic medicine research for mental health disorders The presidential directive instructs the FDA to expedite research and regulatory pathways for psychedelic-based therapies, including suicide prevention applications Definium’s Chief Executive Officer issued a statement welcoming the initiative, emphasizing their DT120 candidate for GAD and MDD The biotech has delivered returns exceeding 300% over the trailing year and reached a 52-week peak at $25.63 Analyst consensus points to a Strong Buy rating with a mean price objective of $38.75 — implying approximately 70% potential appreciation Shares of Definium Therapeutics experienced a notable rally on Monday following President Donald Trump’s signing of an Executive Order designed to accelerate the development of psychedelic-based treatments for mental health conditions. BREAKING: President Trump announces historic reforms to accelerate access to new medical research and treatments based on psychedelic drugs. Trump will sign an executive order directing the FDA to expedite their review of certain psychedelics already designated as breakthrough… pic.twitter.com/16QIo6Fwbt — Fox News (@FoxNews) April 18, 2026 The presidential directive emphasized the therapeutic promise of psychedelics for conditions such as depression, anxiety, and suicide risk. It further directed the FDA to eliminate regulatory obstacles that have historically delayed progress in this research area. DFTX shares climbed 13.71% during premarket activity. Over the past year, the stock has delivered gains surpassing 300%, touching a new 52-week high of $25.63 during Monday’s session. Definium Therapeutics, Inc. (DFTX) Definium CEO Rob Barrow released a statement praising the administration’s action. He expressed that the company “applauds the Administration’s recognition that psychedelic medicines may represent meaningfu...